Ellen Mary Lavoie Smith

12PUBLICATIONS
60CO-AUTHORS
ChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

|Apr 29, 2026
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Oct 28, 2025
A Pilot Study: Comparative Effects of Green Tea Extract and Duloxetine on Oxaliplatin-Induced Allodynia in a Murine Model.

Michael Daniel, Stacie Totsch, Peng Li

|Sep 23, 2025
Neuroprotective interventions to prevent chemotherapy-related cognitive impairment in breast cancer survivors: A systematic review.

Heather Shelton, Marie Bakitas, Pamela G Bowen

|Jan 20, 2024
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper.

Paola Alberti, Andreas A Argyriou, Jordi Bruna

|Jan 17, 2024
Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1).

Ellen M Lavoie Smith, Youmin Cho, Shauna Hillman

Pageof 2

Frequent Collaborators

3 joint publications

David Zahrieh

2 joint publications

Youmin Cho

2 joint publications

Minji Lee

2 joint publications

Yun Jiang